Member Info for alextak

I'm picturing Zen Sujood, is sitting in a corner, with his gleaming third eye on his forehead, his hand, led by supernatural powers, is drawing an AVCT forecast chart

@Sujood

How wonderful that even per chance, you have taken note of my existence and additionally with such excellent metaphoric expression.

The sun is shining but it's your message that makes my day really bright. 🙏

Sujood is just another poster , he is not an Oracle

If Sujood is really is so awesome why doesn't he teleport behind me and slam my face onto the keyboarolhhjjfdjuusoodbfhzoakcblkqoscsnjqpqkc

Avacta’s flagship AVA6000 continues to go from strength to strength, though the real turning point could well be hard data from the Phase 1A clinical trials. The treatment is designed to deliver higher doses of chemotherapy, but without side effects — and where many others have failed, early results look extremely promising.

Having said this, short-term financing needs to be looked at, with CEO Alastair Smith favouring non-dilutive terms.

By Charles Archer

Https://ukinvestormagazine.co.uk/premier-african-minerals-tekcapital-and-avacta-with-charles-archer/

~45:50

Do NOT Click

https://www.fool.co.uk/2023/09/11/if-id-invested-1000-in-avacta-shares-5-years-ago-heres-how-much-id-have-now/

🪠

Https://www.newstong.co.kr/mobile/NewsView.aspx?seq=12020786&allSeq=21&txtSearch=&cate=0&cnt=-5&subCate=2&order=default&newsNo=20

27k @ ~130🍻

Https://www.benzinga.com/pressreleases/23/09/34170976/novel-spectrometry-platforms-market-know-the-untapped-revenue-growth-opportunities

🟩

🗣️

⚽🏀⚽⚾🔐🔓🔒🔏's

BBC

https://youtu.be/mpli_jMQ5lI?feature=shared

Https://www.reuters.com/markets/deals/medical-tech-firm-danaher-buy-abcam-deal-valued-57-bln-2023-08-28/

I will see myself out 🤦‍♂️

https://tiengtrunghaato.edu.vn/umar-kamani-net-worth/

Another report,nothing special

https://www.digitaljournal.com/pr/news/getnews/soft-tissue-sarcoma-pipeline-drugs-analysis-report-2023-fda-approvals-clinical-trials-therapies-mechanism-of-action-route-of-administration-by-delveinsight-oncotherapy-science-inc-foghorn

Https://m.antpedia.com/ibook/pn/759375.html

Just nother report

(Avacta as key player)

https://finance.yahoo.com/news/global-car-t-cell-therapy-085100267.html

Https://www.biorxiv.org/content/10.1101/2023.08.22.554342v1

From Wuhan

🤧

https://www.wuhanty.com/news/show-34931.html

Don't you hate it when someone answers their own questions? I do.

Probably not